These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 16871543)
1. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543 [TBL] [Abstract][Full Text] [Related]
2. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107 [TBL] [Abstract][Full Text] [Related]
3. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Huynh H; Chow PK; Ooi LL; Soo KC Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812 [TBL] [Abstract][Full Text] [Related]
4. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of humbug gene overexpression in stage II colon cancer. Wang J; de la Monte SM; Sabo E; Kethu S; Tavares R; Branda M; Simao L; Wands JR; Resnick MB Hum Pathol; 2007 Jan; 38(1):17-25. PubMed ID: 17020779 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer. Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198 [TBL] [Abstract][Full Text] [Related]
7. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population. Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788 [TBL] [Abstract][Full Text] [Related]
8. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines. Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416 [TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma. Seo JH; Park BC Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600 [TBL] [Abstract][Full Text] [Related]
11. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629 [TBL] [Abstract][Full Text] [Related]
12. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma]. Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394 [TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Breuhahn K; Vreden S; Haddad R; Beckebaum S; Stippel D; Flemming P; Nussbaum T; Caselmann WH; Haab BB; Schirmacher P Cancer Res; 2004 Sep; 64(17):6058-64. PubMed ID: 15342387 [TBL] [Abstract][Full Text] [Related]
15. Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells. Lee JY; Han CY; Yang JW; Smith C; Kim SK; Lee EY; Kim SG; Kang KW Mol Pharmacol; 2007 Oct; 72(4):1082-93. PubMed ID: 17615245 [TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development. Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177 [TBL] [Abstract][Full Text] [Related]
17. Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Yoshida T; Hisamoto T; Akiba J; Koga H; Nakamura K; Tokunaga Y; Hanada S; Kumemura H; Maeyama M; Harada M; Ogata H; Yano H; Kojiro M; Ueno T; Yoshimura A; Sata M Oncogene; 2006 Oct; 25(45):6056-66. PubMed ID: 16652141 [TBL] [Abstract][Full Text] [Related]
18. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995 [TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma. Liu AW; Cai J; Zhao XL; Xu AM; Fu HQ; Nian H; Zhang SH J Clin Pathol; 2009 Nov; 62(11):1003-8. PubMed ID: 19861558 [TBL] [Abstract][Full Text] [Related]
20. Aflatoxin B1 modulates the insulin-like growth factor-2 dependent signaling axis. Ubagai T; Kikuchi T; Fukusato T; Ono Y Toxicol In Vitro; 2010 Apr; 24(3):783-9. PubMed ID: 20036727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]